Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 6 studies | 24% ± 10% | |
astrocyte | 3 studies | 27% ± 13% |
Insufficient scRNA-seq data for expression of PHEX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 154.20 | 2577 / 2642 | 76% | 2.93 | 536 / 705 |
thymus | 98% | 362.39 | 641 / 653 | 72% | 25.93 | 435 / 605 |
breast | 87% | 153.21 | 399 / 459 | 73% | 2.94 | 811 / 1118 |
lung | 100% | 875.30 | 577 / 578 | 50% | 1.47 | 579 / 1155 |
uterus | 95% | 467.29 | 161 / 170 | 42% | 2.92 | 191 / 459 |
esophagus | 81% | 129.88 | 1164 / 1445 | 37% | 1.00 | 68 / 183 |
ovary | 91% | 327.64 | 164 / 180 | 14% | 0.37 | 59 / 430 |
prostate | 93% | 122.68 | 229 / 245 | 9% | 0.14 | 47 / 502 |
skin | 67% | 40.29 | 1204 / 1809 | 34% | 1.05 | 162 / 472 |
spleen | 87% | 76.72 | 209 / 241 | 0% | 0 | 0 / 0 |
intestine | 77% | 74.95 | 748 / 966 | 6% | 0.12 | 31 / 527 |
kidney | 49% | 23.79 | 44 / 89 | 27% | 0.74 | 246 / 901 |
bladder | 43% | 18.48 | 9 / 21 | 24% | 0.82 | 120 / 504 |
blood vessel | 52% | 32.64 | 695 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 2.15 | 10 / 29 |
adrenal gland | 30% | 17.81 | 77 / 258 | 3% | 0.09 | 7 / 230 |
tonsil | 0% | 0 | 0 / 0 | 24% | 0.43 | 11 / 45 |
stomach | 15% | 6.12 | 55 / 359 | 7% | 0.12 | 21 / 286 |
adipose | 22% | 9.41 | 260 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 25.12 | 174 / 929 | 0% | 0 | 0 / 0 |
pancreas | 9% | 3.05 | 28 / 328 | 8% | 0.14 | 15 / 178 |
liver | 1% | 0.42 | 3 / 226 | 11% | 0.33 | 46 / 406 |
heart | 9% | 3.56 | 75 / 861 | 0% | 0 | 0 / 0 |
muscle | 4% | 3.43 | 35 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990418 | Biological process | response to insulin-like growth factor stimulus |
GO_0030324 | Biological process | lung development |
GO_0042476 | Biological process | odontogenesis |
GO_0071305 | Biological process | cellular response to vitamin D |
GO_0016485 | Biological process | protein processing |
GO_0071374 | Biological process | cellular response to parathyroid hormone stimulus |
GO_1904383 | Biological process | response to sodium phosphate |
GO_0007267 | Biological process | cell-cell signaling |
GO_0060416 | Biological process | response to growth hormone |
GO_0036211 | Biological process | protein modification process |
GO_0006508 | Biological process | proteolysis |
GO_0030282 | Biological process | bone mineralization |
GO_0001501 | Biological process | skeletal system development |
GO_0019637 | Biological process | organophosphate metabolic process |
GO_0060348 | Biological process | bone development |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PHEX |
Protein name | Phosphate regulating endopeptidase X-linked Phosphate-regulating neutral endopeptidase PHEX (EC 3.4.24.-) (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein) (HYP) |
Synonyms | PEX |
Description | FUNCTION: Peptidase that cleaves SIBLING (small integrin-binding ligand, N-linked glycoprotein)-derived ASARM peptides, thus regulating their biological activity . Cleaves ASARM peptides between Ser and Glu or Asp residues . Regulates osteogenic cell differentiation and bone mineralization through the cleavage of the MEPE-derived ASARM peptide . Promotes dentin mineralization and renal phosphate reabsorption by cleaving DMP1- and MEPE-derived ASARM peptides . Inhibits the cleavage of MEPE by CTSB/cathepsin B thus preventing MEPE degradation . . |
Accessions | ENST00000684356.1 A0A804HKT0 ENST00000684143.1 P78562 ENST00000683289.1 A0A804HKN7 A0A804HL45 A0A804HJR7 A0A804HLA0 ENST00000682888.1 ENST00000683162.1 ENST00000379374.5 |